by Walter Gunzburg | Jul 28, 2020 | Press Release
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova announced today that they are the recipients of the Emerging Enterprises 2014 Best Innovation award. The award was presented at a gala dinner and awards ceremony held at the Ritz Carlton hotel in Singapore and was organised and hosted by the main sponsor,...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova announced the opening of their new company facilities at Synapse, within Biopolis, a world-class biomedical sciences hub where key research institutes and organisations are located. The Company occupies lab and office space within one self contained unit...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs). These EVs are known...
